Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical gastroenterology 2006-01, Vol.40 (1), p.88
Hauptverfasser:	Sato, Shuichi, Furuta, Kouichiro, Miyake, Tatsuya, Mishiro, Tomoko, Kohge, Naruaki, Akagi, Shuji, Uchida, Yasushi, Rumi, M A K, Ishihara, Shunji, Adachi, Kyouichi, Kinoshita, Yoshikazu
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia, Hemolytic - chemically induced Drug Therapy, Combination Female Hemoglobins - analysis Hemoglobins - drug effects Hepatitis C, Chronic - drug therapy Humans Interferon alpha-2 Interferon-alpha - adverse effects Interferon-alpha - therapeutic use Male Middle Aged Natriuretic Peptide, Brain - blood Natriuretic Peptide, Brain - drug effects Recombinant Proteins Ribavirin - adverse effects Ribavirin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0192-0790